NATURALS
75
Micro-Organisms
Corneous Layer
Epidermis Living
Pro-Inflammatory Cytokines and Inflammatory Mediators (IL-1, TNF a, Growth Factors)
Inflamed Cells Figure 6: The skin chemical barrier
human epidermis (RHE) using qPCR technology for bacterial counting. Overall, the experimental conditions
demonstrated a decrease in bacterial adhesion when the reconstructed human epidermis was treated with the skincare active at concentrations of 0.5%, 1%, and 2.5%. The product consistently increased the
proportion of Staphylococcus epidermidis while reducing the presence of Staphylococcus aureus and, to a lesser extent, Corynebacterium xerosis. This indicates the potential of the skincare active to modulate the skin’s microbial environment in a way that promotes a healthier and more balanced skin microbiota, resulting in improved skin clarity and balance. By evaluating the anti-microbial effect of
the skincare active on human keratinocytes, the study aimed to determine the product’s ability
S.epidermidis ■ C.xerosis ■
S.aureus ■
C.acnes ■
120 100 80 60 40 20 0
+9% +21% +35% +51% +35% Control 0.5% 1% 2.5%
Figure 7: Evaluation of the adhesion of four bacterial strains: Staphylococcus epidermidis, Staphylococcus aureus, Corynebacterium xerosis, and Cutibacterium acnes
+57% +64% +8% +13% +28%
+7% +11%
+25%
+8% +8%
+20%
Constituent Antimicrobial Peptides (Psoriasine)
Induced Antimicrobial Peptides (β-Defensines, Rnase 7, LL-37)
www.personalcaremagazine.com
October 2023 PERSONAL CARE
Ratio
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108